{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:41:47Z","timestamp":1792827707228,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K07 CA230182"],"award-info":[{"award-number":["K07 CA230182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Maryland Department of Health\u2019s Cigarette Restitution Fund Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Though obesity, measured by body mass index (BMI), is an established risk factor for several cancer sites, there is conflicting evidence on whether obesity increases prostate cancer risk or mortality and, if it does, whether it increases risk directly or indirectly by affecting prostate cancer screening efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined associations between BMI and prostate cancer screening outcomes, incidence, and mortality in men randomly assigned to the intervention arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (n\u2009=\u200936\u200a756) between 1993 and 2001. Participants received annual screening with the prostate-specific antigen test and digital rectal exam. Associations between baseline BMI and screening outcomes were assessed via multinomial logistic regression, and associations with prostate cancer incidence and mortality were assessed via Cox proportional hazards regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Individuals with higher BMI were less likely to screen positive via the prostate-specific antigen test and\/or digital rectal exam and more likely to have an inadequate screen (all Ptrend\u2009&amp;lt;\u2009.01). Higher BMI was inversely associated with prostate cancer incidence (per 5\u2009kg\/m2 BMI increase: hazard ratio [HR] = 0.94, 95% confidence interval [CI] = 0.91 to 0.97), including incidence of early stage (HR = 0.94, 95% CI = 0.90 to 0.97) and advanced-stage (HR = 0.91, 95% CI = 0.82 to 1.02) disease, but positively associated with prostate cancer mortality (HR = 1.21, 95% CI = 1.06 to 1.37). The association with mortality was not modified by screening outcome (Pinteraction\u2009=\u2009.13).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Within this screened population, individuals with higher BMI had lower risk of prostate cancer diagnosis but higher risk of prostate cancer mortality. As higher BMI was not positively associated with advanced-stage prostate cancer risk, the increased mortality is unlikely to be due to delayed prostate cancer detection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djad113","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T16:33:45Z","timestamp":1686674025000},"page":"1506-1514","source":"Crossref","is-referenced-by-count":26,"title":["Obesity and prostate cancer screening, incidence, and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial"],"prefix":"10.1093","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8932-5028","authenticated-orcid":false,"given":"Lauren M","family":"Hurwitz","sequence":"first","affiliation":[{"name":"Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services , Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Dogbe","sequence":"additional","affiliation":[{"name":"Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services , Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn Hughes","family":"Barry","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, University of Maryland School of Medicine , Baltimore, MD, USA"},{"name":"Program in Oncology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center , Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5294-5485","authenticated-orcid":false,"given":"Stella","family":"Koutros","sequence":"additional","affiliation":[{"name":"Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services , Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja I","family":"Berndt","sequence":"additional","affiliation":[{"name":"Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services , Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"3","key":"2023120620173360800_djad113-B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"2023120620173360800_djad113-B2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2013viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"2023120620173360800_djad113-B3","author":"World Cancer Research Fund International Continuous Update Project","year":"2014"},{"issue":"1","key":"2023120620173360800_djad113-B4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.annonc.2019.09.007","article-title":"Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in the pooling project of prospective studies of diet and cancer","volume":"31","author":"Genkinger","year":"2020","journal-title":"Ann Oncol"},{"issue":"8","key":"2023120620173360800_djad113-B5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10552-006-0049-z","article-title":"Body size and composition and prostate cancer risk: systematic review and meta-regression analysis","volume":"17","author":"MacInnis","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2023120620173360800_djad113-B6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/advances\/nmab153","article-title":"Body composition and prostate cancer risk: a systematic review of observational studies","volume":"13","author":"Purcell","year":"2022","journal-title":"Adv Nutr"},{"issue":"3","key":"2023120620173360800_djad113-B7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1055-9965.EPI-08-0938","article-title":"Serum prostate-specific antigen hemodilution among obese men undergoing screening in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"18","author":"Grubb","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2023120620173360800_djad113-B8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/ajcp\/aqx157","article-title":"Serum prostate-specific antigen (PSA) concentration, PSA mass, and obesity: a mathematical analysis","volume":"149","author":"Vollmer","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2023120620173360800_djad113-B9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10552-020-01291-3","article-title":"Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen","volume":"31","author":"Harrison","year":"2020","journal-title":"Cancer Causes Control"},{"issue":"2","key":"2023120620173360800_djad113-B10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/cncr.21603","article-title":"Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase","volume":"106","author":"Kristal","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"2023120620173360800_djad113-B11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/1055-9965.EPI-06-0588","article-title":"Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004","volume":"16","author":"Werny","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2023120620173360800_djad113-B12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/pros.20704","article-title":"Obesity and screening PSA levels among men undergoing an annual physical exam","volume":"68","author":"Rundle","year":"2008","journal-title":"Prostate"},{"issue":"3","key":"2023120620173360800_djad113-B13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.urology.2008.04.008","article-title":"Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004-2006","volume":"72","author":"Ando","year":"2008","journal-title":"Urology"},{"issue":"3","key":"2023120620173360800_djad113-B14","first-page":"4557","article-title":"An inverse association of body mass index and prostate-specific antigen in northwest men of China: a population-based analysis","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"2023120620173360800_djad113-B15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/pros.23285","article-title":"Association of obesity-related hemodilution of prostate-specific antigen, dihydrotestosterone, and testosterone","volume":"77","author":"Klaassen","year":"2017","journal-title":"Prostate"},{"issue":"19","key":"2023120620173360800_djad113-B16","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","article-title":"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer","volume":"298","author":"Ba\u00f1ez","year":"2007","journal-title":"JAMA"},{"issue":"9","key":"2023120620173360800_djad113-B17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.amjmed.2010.05.011","article-title":"Obesity and prostate cancer detection: insights from three national surveys","volume":"123","author":"Parekh","year":"2010","journal-title":"Am J Med"},{"issue":"8","key":"2023120620173360800_djad113-B18","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.puhe.2004.09.002","article-title":"Obesity and prostate cancer screening in the USA","volume":"119","author":"Fontaine","year":"2005","journal-title":"Public Health"},{"issue":"7","key":"2023120620173360800_djad113-B19","doi-asserted-by":"publisher","first-page":"e011356","DOI":"10.1136\/bmjopen-2016-011356","article-title":"Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?","volume":"6","author":"Nderitu","year":"2016","journal-title":"BMJ Open"},{"issue":"13","key":"2023120620173360800_djad113-B20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/pros.20377","article-title":"Obesity and prostate cancer screening among African-American and Caucasian men","volume":"66","author":"Fowke","year":"2006","journal-title":"Prostate"},{"issue":"36","key":"2023120620173360800_djad113-B21","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1200\/j.clinoncol.2016.68.1965","article-title":"Biases in recommendations for and acceptance of prostate biopsy significantly affect assessment of prostate cancer risk factors: results from two large randomized clinical trials","volume":"34","author":"Tangen","year":"2016","journal-title":"J Clin Oncol"},{"key":"2023120620173360800_djad113-B22","volume-title":"Current Status and Response to the Global Obesity Pandemic: Proceedings of a Workshop","author":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board; Roundtable on Obesity Solutions","year":"2019"},{"issue":"3","key":"2023120620173360800_djad113-B23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999-2008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"issue":"suppl 6","key":"2023120620173360800_djad113-B24","doi-asserted-by":"crossref","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","article-title":"Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","volume":"21","author":"Prorok","year":"2000","journal-title":"Control Clin Trials"},{"issue":"13","key":"2023120620173360800_djad113-B25","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"2023120620173360800_djad113-B26","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee","volume-title":"World Health Organ Tech Rep Ser","year":"1995"},{"issue":"5","key":"2023120620173360800_djad113-B27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/bju.14580","article-title":"Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial","volume":"123","author":"Pinsky","year":"2019","journal-title":"BJU Int"},{"issue":"suppl 6","key":"2023120620173360800_djad113-B28","doi-asserted-by":"publisher","first-page":"400S","DOI":"10.1016\/s0197-2456(00)00095-7","article-title":"Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","volume":"21","author":"Miller","year":"2000","journal-title":"Control Clin Trials"},{"issue":"6","key":"2023120620173360800_djad113-B29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/jnci\/djaa154","article-title":"Recommended definitions of aggressive prostate cancer for etiologic epidemiologic research","volume":"113","author":"Hurwitz","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2023120620173360800_djad113-B30","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis (Springer Series in Statistics)","author":"Harrell","year":"2001"},{"issue":"1","key":"2023120620173360800_djad113-B31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10552-005-0378-3","article-title":"Are findings from studies of obesity and prostate cancer really in conflict?","volume":"17","author":"Freedland","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"10","key":"2023120620173360800_djad113-B32","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","article-title":"Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial","volume":"15","author":"Gong","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"2023120620173360800_djad113-B33","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/annonc\/mdr603","article-title":"Body mass index and incidence of localized and advanced prostate cancer\u2013a dose-response meta-analysis of prospective studies","volume":"23","author":"Discacciati","year":"2012","journal-title":"Ann Oncol"},{"issue":"7","key":"2023120620173360800_djad113-B34","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/ijc.22788","article-title":"Risk factors for prostate cancer incidence and progression in the health professionals follow-up study","volume":"121","author":"Giovannucci","year":"2007","journal-title":"Int J Cancer"},{"issue":"5","key":"2023120620173360800_djad113-B35","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"Eur Urol"},{"key":"2023120620173360800_djad113-B36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/epirev\/mxm006","article-title":"Obesity and prostate cancer: making sense out of apparently conflicting data","volume":"29","author":"Freedland","year":"2007","journal-title":"Epidemiol Rev"},{"issue":"4","key":"2023120620173360800_djad113-B37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/pcan.2011.31","article-title":"Predictive value of digital rectal examination for prostate cancer detection is modified by obesity","volume":"14","author":"Chu","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2023120620173360800_djad113-B38","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.canep.2019.101619","article-title":"Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: examining race and BMI","volume":"63","author":"Tangen","year":"2019","journal-title":"Cancer Epidemiol"},{"issue":"17","key":"2023120620173360800_djad113-B39","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"2023120620173360800_djad113-B40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/cncr.22443","article-title":"Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality","volume":"109","author":"Wright","year":"2007","journal-title":"Cancer"},{"issue":"5","key":"2023120620173360800_djad113-B41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2217\/14796694.3.5.557","article-title":"Obesity and prostate cancer mortality","volume":"3","author":"Kristal","year":"2007","journal-title":"Future Oncol"},{"issue":"1","key":"2023120620173360800_djad113-B42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12916-022-02336-x","article-title":"Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies","volume":"20","author":"Perez-Cornago","year":"2022","journal-title":"BMC Med"},{"issue":"4","key":"2023120620173360800_djad113-B43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"18","key":"2023120620173360800_djad113-B44","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1200\/j.clinoncol.19.02185","article-title":"Postdiagnosis body mass index, weight change, and mortality from prostate cancer, cardiovascular disease, and all causes among survivors of nonmetastatic prostate cancer","volume":"38","author":"Troeschel","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"2023120620173360800_djad113-B45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/pcan.2016.47","article-title":"Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database","volume":"20","author":"Vidal","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"2023120620173360800_djad113-B46","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/cncr.22534","article-title":"Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men","volume":"109","author":"Gong","year":"2007","journal-title":"Cancer"},{"issue":"16","key":"2023120620173360800_djad113-B47","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.3390\/cancers13164169","article-title":"Obesity as a risk factor for prostate cancer mortality: a systematic review and dose-response meta-analysis of 280,199 patients","volume":"13","author":"Rivera-Izquierdo","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2023120620173360800_djad113-B48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10555-022-10054-2","article-title":"The timing of adiposity and changes in the life course on the risk of cancer","volume":"41","author":"Fang","year":"2022","journal-title":"Cancer Metastasis Rev"},{"issue":"S3","key":"2023120620173360800_djad113-B49","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/ijo.2008.87","article-title":"BMI-related errors in the measurement of obesity","volume":"32","author":"Rothman","year":"2008","journal-title":"Int J Obes"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djad113\/51544537\/djad113.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/115\/12\/1506\/54035655\/djad113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/115\/12\/1506\/54035655\/djad113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:44:41Z","timestamp":1701909881000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/115\/12\/1506\/7210260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6,29]]},"published-print":{"date-parts":[[2023,12,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djad113","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,1]]},"published":{"date-parts":[[2023,6,29]]}}}